Cargando…
Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine
A multicenter clinical trial was performed to compare the efficacy and safety of Ginkgo biloba extract EGb 761 and betahistine at recommended doses in patients with vertigo. One hundred and sixty patients (mean age 58 years) were randomly assigned to double-blind treatment with EGb 761 (240 mg per d...
Autores principales: | Sokolova, Larysa, Hoerr, Robert, Mishchenko, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099171/ https://www.ncbi.nlm.nih.gov/pubmed/25057270 http://dx.doi.org/10.1155/2014/682439 |
Ejemplares similares
-
Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
por: Hort, Jakub, et al.
Publicado: (2023) -
The Effect of Ginkgo Biloba (EGb 761) on Epileptic Activity in Rabbits
por: Ivetic, Vesna, et al.
Publicado: (2008) -
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761(®). Findings from a randomized controlled trial
por: Bachinskaya, Natalia, et al.
Publicado: (2011) -
Ginkgo biloba extract EGb 761(®) versus pentoxifylline in chronic tinnitus: a randomized, double-blind clinical trial
por: Procházková, Klára, et al.
Publicado: (2018) -
A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761(®)
por: Hoerr, Robert, et al.
Publicado: (2015)